DANEEN BIOTHERAPEUTICS

About Us

 We are one of the  fastest growing Specialty Pharmaceutical supply chains Start up in India

Who We Are

We at   Daneen Biotherapeutics have the resources to help you access CELL& GENE THERAPY Products ,  innovator drugs, Comparator Drugs, and Reference Listed Drugs (RLD pharmaceutical) for BA/BE studies and Comparator sourcing for clinical trials from the US, EU, UK, and other major countries to India and Vice-Versa .

  • Ensuring Confidentiality of Entire Supply Chain in terms of Product Availability, Authorized sources, Product Identity and Traceability.
  • End to End IMP (Investigational Medicinal Product ) Project Management for Clinical trials including Ancillaries Supplies.

We’re also have a team of healthcare professionals with a passion for pharmacy practice providing boutique Business/Management Consulting and Advisory Services to Pharmaceutical Companies  in the field  of  Emerging Market Access and new medical therapies .

We simplify the  procurement  and delivery of specialty Pharmaceutical products to Patients  by leveraging our expertise  as one of the  trusted specialty pharmaceutical supply chains in India with professionals having decades of experience delivering these critical medications.

Our  dedication  to patient centricity  is unrivaled.

We are with Patients  every step of the way and are proud to support Patients, Pharmacies, pharmaceutical companies conducting clinical trials for new drug development and discovery, CRO, and Sponsors ,Governments by offering a broad specialty product portfolio, emergency ordering,  and integrated end to end  temperature-controlled   supply chain management .

Our Vision

We believe that the pharmacy is essential to improving outcomes – and  the practice of pharmacy holds the  potential to change the future of healthcare by adopting an unrivaled patient centric approach .To be on a relentless pursuit to transform the human Healthcare of low and middle income countries for better.

Our Mission

Democratizing  the Accessibility and Affordability of Life Saving Specialty Medicines and New Medical technologies and therapies for Patients  by Reimagining the Pharmaceutical Supply Chain of future .